and leukotrienes (LT), as well as platelet activating factor (PAF) are produced by the action of phospholipase a 2 (PLA2) on the membrane phospholipid 1-0-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine and subsequent oxidative metabolism of the freed arachidonic acid or acetylation of the remaining 1-alkyl-2-1yso-glycerophosphocholine (lyso-PAF) molecule, respectively. These 22 an effect associated with decreased TNF transcription 14 ( Fig. 1) .
PAF can enhance TNFo production by rat alveolar macrophages 11 and human monocytes 23-2s and myeloid cells. 26 In the macrophages, the activation pathway may involve (Fig. 2) .
